secwatch.observer — SEC 8-K summary
======================================

Issuer:     RetinalGenix Technologies Inc. (RTGN)
CIK:        0001836295
Form:       8-K
Filed at:   2022-02-17T23:59:59+00:00
Accession:  0001493152-22-004875
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RetinalGenix and Diopsys terminate 2019 Option Exchange Agreement; no options ever issued
--------------------------------------------------------------------------------

- Termination effective Feb 14, 2022; Agreement from Oct 8, 2019 never had conditions satisfied.
- No options were issued under the agreement, and the contemplated Exclusive Distribution Agreement was never negotiated.
- Both parties are mutually released from any claims related to the Agreement and its termination.
- RetinalGenix and Diopsys continue discussions toward a potential Exclusive Distribution Agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1836295/000149315222004875/0001493152-22-004875-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1836295/000149315222004875/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-004875

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer